In contrast, ASM patients showed lower levels of CD33 compared to ISM-AHN (p = 0.04), WDSM (p = 0.001), and ISMMC (p = 0.002) cases (Figure 1D). The gene discussed is CD33; the disease is aggressive systemic mastocytosis.